Avalyn Pharma Inc. - 10-Q Filing

Avalyn Pharma Inc. reports Q3 2026 financial results including multi-series preferred stock structures and R&D expense updates.

4 articles from 2 sources · updated November 12, 2026, 21:32 UTC

Coverage

• Ensysce Biosciences, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:30 UTC
• Avalyn Pharma Inc. - 4 Filing SEC EDGAR · November 12, 2026, 16:35 UTC
• Avalyn Pharma reports Q3 results Seeking Alpha · November 12, 2026, 15:17 UTC
• Avalyn Pharma Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:15 UTC